MENU
OSCR
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

OSCR stock forecast, quote, news & analysis

Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members... Show more

A.I.Advisor
published price charts
A.I.Advisor
a Summary for OSCR with price predictions
Nov 05, 2026

OSCR in upward trend: price rose above 50-day moving average on November 03, 2026

OSCR moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend. In 32 of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 58 cases where OSCR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Moving Average Convergence Divergence (MACD) for OSCR just turned positive on November 04, 2026. Looking at past instances where OSCR's MACD turned positive, the stock continued to rise in 35 of 41 cases over the following month. The odds of a continued upward trend are 85%.

Following a +13.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where OSCR advanced for three days, in 232 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

The Aroon Indicator entered an Uptrend today. In 178 of 225 cases where OSCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OSCR as a result. In 63 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

The 10-day moving average for OSCR crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OSCR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

OSCR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating fairly steady price growth. OSCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 35 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.

The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.991) is normal, around the industry mean (3.530). P/E Ratio (20.868) is within average values for comparable stocks, (131.451). OSCR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.618) is also within normal values, averaging (0.569).

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Unitedhealth Group (NYSE:UNH), CVS HEALTH Corp (NYSE:CVS), Elevance Health (NYSE:ELV), Cigna Group (The) (NYSE:CI), Humana (NYSE:HUM), Centene Corp (NYSE:CNC).

Industry description

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

Market Cap

The average market capitalization across the Managed Health Care Industry is 67.89B. The market cap for tickers in the group ranges from 335.99K to 355.2B. UNH holds the highest valuation in this group at 355.2B. The lowest valued company is IHGP at 335.99K.

High and low price notable news

The average weekly price growth across all stocks in the Managed Health Care Industry was 2%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 18%. PGNY experienced the highest price growth at 21%, while CVS experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the Managed Health Care Industry was 59%. For the same stocks of the Industry, the average monthly volume growth was 63% and the average quarterly volume growth was 8%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 38
Price Growth Rating: 32
SMR Rating: 72
Profit Risk Rating: 83
Seasonality Score: 0 (-100 ... +100)
OSCR in upward trend: price rose above 50-day moving average on November 03, 2026